SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
STERIS plc (STE) trades at a trailing P/E of 30.8, forward P/E of 22.1. Trailing earnings yield is 3.25%, forward earnings yield 4.54%. PEG 0.50 (Peter Lynch undervalued ≤1.0). Graham Number is $108.69.
Criteria proven by this page:
- VALUE (41/100, Partial) — mixed signals — some valuation metrics are favorable while others are stretched.
- Forward P/E 22.1 (down from trailing 30.8) — analysts expect earnings to grow, which would improve the valuation.
- PEG Ratio 0.50 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
- Trailing Earnings Yield 3.25% — roughly competitive with bond yields (~4.3%), moderate risk-reward. Forward yield improves to 4.54% as earnings recover.
- Analyst consensus target $256.67 (+14.2% upside) — modest upside expected.
Overall SharesGrow Score: 76/100 with 4/7 criteria passed.
SharesGrow 7-Criteria Score
~
VALUE
41/100
Price-to-Earnings & upside
Proven by this page
✓
HEALTH
100/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — STE
Valuation Multiples
P/E (TTM)30.8
Forward P/E22.1
PEG Ratio0.50
Forward PEG0.34
P/B Ratio3.04
P/S Ratio3.73
EV/EBITDA17.1
Per Share Data
EPS (TTM)$7.20
Forward EPS (Est.)$10.20
Book Value / Share$72.92
Revenue / Share$59.29
FCF / Share$9.33
Yields & Fair Value
Earnings Yield3.25%
Forward Earnings Yield4.54%
Dividend Yield1.11%
Graham Number$108.69
SharesGrow IV$221.37 (-1.5%)
Analyst Target$256.67 (+14.2%)
Historical Valuation
| Year |
P/E (TTM) |
PEG Ratio |
P/B Ratio |
P/S Ratio |
Dividend Yield |
| 2016 |
45.3 |
-1.47 |
1.66 |
2.24 |
1.30% |
| 2017 |
54.0 |
-3.03 |
2.12 |
2.27 |
1.57% |
| 2018 |
27.3 |
0.17 |
2.48 |
3.03 |
1.30% |
| 2019 |
35.4 |
7.13 |
3.39 |
3.87 |
1.04% |
| 2020 |
29.1 |
0.86 |
3.48 |
3.92 |
1.04% |
| 2021 |
40.8 |
-13.10 |
4.18 |
5.22 |
0.82% |
| 2022 |
96.7 |
-2.09 |
3.61 |
5.58 |
0.69% |
| 2023 |
178.2 |
-3.12 |
3.14 |
4.20 |
0.96% |
| 2024 |
57.7 |
0.22 |
3.46 |
4.25 |
0.92% |
| 2025 |
36.3 |
0.58 |
3.38 |
4.09 |
0.98% |
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$1.56 |
$2.24B |
$110.76M |
4.9% |
| 2017 |
$1.28 |
$2.61B |
$109.97M |
4.2% |
| 2018 |
$3.39 |
$2.62B |
$290.92M |
11.1% |
| 2019 |
$3.56 |
$2.78B |
$304.05M |
10.9% |
| 2020 |
$4.76 |
$3.03B |
$407.66M |
13.5% |
| 2021 |
$4.63 |
$3.11B |
$397.4M |
12.8% |
| 2022 |
$2.48 |
$4.59B |
$243.89M |
5.3% |
| 2023 |
$1.07 |
$4.54B |
$107.03M |
2.4% |
| 2024 |
$3.81 |
$5.14B |
$378.24M |
7.4% |
| 2025 |
$6.16 |
$5.46B |
$614.64M |
11.3% |
Analyst Estimates
| Year |
EPS (Avg) |
EPS Range |
Revenue (Avg) |
Revenue Range |
Analysts |
| 2026 |
$10.20 |
$10.18 – $10.23 |
$5.94B |
$5.92B – $5.95B |
6 |
| 2027 |
$11.10 |
$10.89 – $11.30 |
$6.3B |
$6.19B – $6.35B |
6 |
| 2028 |
$12.26 |
$11.83 – $12.48 |
$6.74B |
$6.73B – $6.74B |
5 |
| 2029 |
$10.31 |
$10.08 – $10.40 |
$7.11B |
$6.98B – $7.15B |
1 |
